Grace R J, Kendall R G, Chapman C, Hartley A E, Barnard D L, Norfolk D R
Department of Haematology, General Infirmary, Leeds, U.K.
Eur J Haematol. 1991 Aug;47(2):81-5. doi: 10.1111/j.1600-0609.1991.tb00126.x.
Serial serum erythropoietin levels were measured in 10 consecutive patients undergoing allogeneic bone marrow transplantation. Observed erythropoietin levels are compared with those predicted from a large control population of anaemic patients not receiving chemotherapy. There was an initial acute rise in serum erythropoietin, peaking between days 1 and 4 after marrow transfusion, which was unrelated to changes in haemoglobin concentration. Patients maintained serum erythropoietin concentrations at around twice the predicted level for the first 2 weeks following transplantation, with a gradual fall into the expected range by wk 3. Erythropoietin levels did not change with episodes of bacterial infection or acute graft-versus-host disease. A patient with severe aplastic anaemia had initial successful engraftment with normalisation of erythropoietin levels, but showed a marked and amplified rise in erythropoietin 2 wk before falling peripheral blood counts indicated failure of the bone marrow graft.
对10例连续接受异基因骨髓移植的患者进行了系列血清促红细胞生成素水平测定。将观察到的促红细胞生成素水平与来自未接受化疗的大量贫血患者对照人群所预测的水平进行比较。血清促红细胞生成素最初出现急性升高,在骨髓输注后第1天至第4天达到峰值,这与血红蛋白浓度的变化无关。患者在移植后的前2周内将血清促红细胞生成素浓度维持在预测水平的两倍左右,到第3周逐渐降至预期范围。促红细胞生成素水平在细菌感染或急性移植物抗宿主病发作时没有变化。一名严重再生障碍性贫血患者最初移植成功,促红细胞生成素水平恢复正常,但在外周血细胞计数下降表明骨髓移植失败前2周,促红细胞生成素出现明显且放大的升高。